The medication's half-life of about 7 days means that missing your usual injection window by several hours rarely causes problems, but drifting your schedule by multiple days can reduce effectiveness
By combining both signals in one weekly shot, tirzepatide lowers blood sugar and helps many people lose a large amount of body weight
A positive correlation between plasma levels of L-Cn and serum levels of ALT and AST was found ( Figure 1B )
And Eli Lilly researchers are conducting clinical trials for the newest GLP-1 drug, called retatrutide, which could help patients lose as much as 30% of their body weight
Compared with placebo, GLP-1s increase risk of nausea, vomiting, burping, constipation, diarrhea, GERD, and dyspepsia (indigestion)